Easy Access and Express Report Delivery Service
Norovirus Vaccine Market, Global Outlook and Forecast 2023-2029
Report ID
36935
Publisher
Market Monitor Global
Published Date
17-Oct
Delivery Format
PDF
No of Report Page
76
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Norovirus Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Norovirus Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Norovirus Vaccine, challenges faced by the industry, and potential opportunities for market players. The global Norovirus Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Norovirus Vaccine market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Norovirus Vaccine market. Additionally, the growing consumer demand present avenues for market expansion. The global Norovirus Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Norovirus, a human caliciviridae virus, is mainly transmitted through the fecal-oral route and is highly contagious. It has no obvious pathogenicity in healthy people, but can cause serious illness and complications in immunocompromised patients, the elderly and children. It can last for a long time, and the main symptoms of infection are diarrhea and vomiting. Norovirus vaccines can effectively prevent viral infections, but the current existing vaccines fail to meet clinical needs, resulting in a large demand gap. As people's health awareness increases, there will be a huge demand for norovirus vaccines in the future. Key Features: The research report on the Norovirus Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Norovirus Vaccine market. Market Overview: The report provides a comprehensive overview of the Norovirus Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Bivalent, Quadrivalent), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Norovirus Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Norovirus Vaccine market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Norovirus Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Norovirus Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Norovirus Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Norovirus Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Norovirus Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Norovirus Vaccine market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Norovirus Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. Market segment by Type Bivalent Quadrivalent Hexavalent Market segment by Application Hospital Clinic Others Global Norovirus Vaccine Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Hillevax Vaxart Moderna UMN Pharma Daiichi Sankyo Kanghua Biology Beijing Institute of Biological Products Zhifei Bio China Biotechnology Co., Ltd. North China Pharmaceutical Outline of Major Chapters: Chapter 1: Introduces the definition of Norovirus Vaccine, market overview. Chapter 2: Global Norovirus Vaccine market size in revenue and volume. Chapter 3: Detailed analysis of Norovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Norovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Norovirus Vaccine capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Norovirus Vaccine Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Norovirus Vaccine Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Norovirus Vaccine Overall Market Size 2.1 Global Norovirus Vaccine Market Size: 2022 VS 2029 2.2 Global Norovirus Vaccine Revenue, Prospects & Forecasts: 2018-2029 2.3 Global Norovirus Vaccine Sales: 2018-2029 3 Company Landscape 3.1 Top Norovirus Vaccine Players in Global Market 3.2 Top Global Norovirus Vaccine Companies Ranked by Revenue 3.3 Global Norovirus Vaccine Revenue by Companies 3.4 Global Norovirus Vaccine Sales by Companies 3.5 Global Norovirus Vaccine Price by Manufacturer (2018-2023) 3.6 Top 3 and Top 5 Norovirus Vaccine Companies in Global Market, by Revenue in 2022 3.7 Global Manufacturers Norovirus Vaccine Product Type 3.8 Tier 1, Tier 2 and Tier 3 Norovirus Vaccine Players in Global Market 3.8.1 List of Global Tier 1 Norovirus Vaccine Companies 3.8.2 List of Global Tier 2 and Tier 3 Norovirus Vaccine Companies 4 Sights by Product 4.1 Overview 4.1.1 By Type - Global Norovirus Vaccine Market Size Markets, 2022 & 2029 4.1.2 Bivalent 4.1.3 Quadrivalent 4.1.4 Hexavalent 4.2 By Type - Global Norovirus Vaccine Revenue & Forecasts 4.2.1 By Type - Global Norovirus Vaccine Revenue, 2018-2023 4.2.2 By Type - Global Norovirus Vaccine Revenue, 2024-2029 4.2.3 By Type - Global Norovirus Vaccine Revenue Market Share, 2018-2029 4.3 By Type - Global Norovirus Vaccine Sales & Forecasts 4.3.1 By Type - Global Norovirus Vaccine Sales, 2018-2023 4.3.2 By Type - Global Norovirus Vaccine Sales, 2024-2029 4.3.3 By Type - Global Norovirus Vaccine Sales Market Share, 2018-2029 4.4 By Type - Global Norovirus Vaccine Price (Manufacturers Selling Prices), 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Norovirus Vaccine Market Size, 2022 & 2029 5.1.2 Hospital 5.1.3 Clinic 5.1.4 Others 5.2 By Application - Global Norovirus Vaccine Revenue & Forecasts 5.2.1 By Application - Global Norovirus Vaccine Revenue, 2018-2023 5.2.2 By Application - Global Norovirus Vaccine Revenue, 2024-2029 5.2.3 By Application - Global Norovirus Vaccine Revenue Market Share, 2018-2029 5.3 By Application - Global Norovirus Vaccine Sales & Forecasts 5.3.1 By Application - Global Norovirus Vaccine Sales, 2018-2023 5.3.2 By Application - Global Norovirus Vaccine Sales, 2024-2029 5.3.3 By Application - Global Norovirus Vaccine Sales Market Share, 2018-2029 5.4 By Application - Global Norovirus Vaccine Price (Manufacturers Selling Prices), 2018-2029 6 Sights by Region 6.1 By Region - Global Norovirus Vaccine Market Size, 2022 & 2029 6.2 By Region - Global Norovirus Vaccine Revenue & Forecasts 6.2.1 By Region - Global Norovirus Vaccine Revenue, 2018-2023 6.2.2 By Region - Global Norovirus Vaccine Revenue, 2024-2029 6.2.3 By Region - Global Norovirus Vaccine Revenue Market Share, 2018-2029 6.3 By Region - Global Norovirus Vaccine Sales & Forecasts 6.3.1 By Region - Global Norovirus Vaccine Sales, 2018-2023 6.3.2 By Region - Global Norovirus Vaccine Sales, 2024-2029 6.3.3 By Region - Global Norovirus Vaccine Sales Market Share, 2018-2029 6.4 North America 6.4.1 By Country - North America Norovirus Vaccine Revenue, 2018-2029 6.4.2 By Country - North America Norovirus Vaccine Sales, 2018-2029 6.4.3 US Norovirus Vaccine Market Size, 2018-2029 6.4.4 Canada Norovirus Vaccine Market Size, 2018-2029 6.4.5 Mexico Norovirus Vaccine Market Size, 2018-2029 6.5 Europe 6.5.1 By Country - Europe Norovirus Vaccine Revenue, 2018-2029 6.5.2 By Country - Europe Norovirus Vaccine Sales, 2018-2029 6.5.3 Germany Norovirus Vaccine Market Size, 2018-2029 6.5.4 France Norovirus Vaccine Market Size, 2018-2029 6.5.5 U.K. Norovirus Vaccine Market Size, 2018-2029 6.5.6 Italy Norovirus Vaccine Market Size, 2018-2029 6.5.7 Russia Norovirus Vaccine Market Size, 2018-2029 6.5.8 Nordic Countries Norovirus Vaccine Market Size, 2018-2029 6.5.9 Benelux Norovirus Vaccine Market Size, 2018-2029 6.6 Asia 6.6.1 By Region - Asia Norovirus Vaccine Revenue, 2018-2029 6.6.2 By Region - Asia Norovirus Vaccine Sales, 2018-2029 6.6.3 China Norovirus Vaccine Market Size, 2018-2029 6.6.4 Japan Norovirus Vaccine Market Size, 2018-2029 6.6.5 South Korea Norovirus Vaccine Market Size, 2018-2029 6.6.6 Southeast Asia Norovirus Vaccine Market Size, 2018-2029 6.6.7 India Norovirus Vaccine Market Size, 2018-2029 6.7 South America 6.7.1 By Country - South America Norovirus Vaccine Revenue, 2018-2029 6.7.2 By Country - South America Norovirus Vaccine Sales, 2018-2029 6.7.3 Brazil Norovirus Vaccine Market Size, 2018-2029 6.7.4 Argentina Norovirus Vaccine Market Size, 2018-2029 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Norovirus Vaccine Revenue, 2018-2029 6.8.2 By Country - Middle East & Africa Norovirus Vaccine Sales, 2018-2029 6.8.3 Turkey Norovirus Vaccine Market Size, 2018-2029 6.8.4 Israel Norovirus Vaccine Market Size, 2018-2029 6.8.5 Saudi Arabia Norovirus Vaccine Market Size, 2018-2029 6.8.6 UAE Norovirus Vaccine Market Size, 2018-2029 7 Manufacturers & Brands Profiles 7.1 Hillevax 7.1.1 Hillevax Company Summary 7.1.2 Hillevax Business Overview 7.1.3 Hillevax Norovirus Vaccine Major Product Offerings 7.1.4 Hillevax Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.1.5 Hillevax Key News & Latest Developments 7.2 Vaxart 7.2.1 Vaxart Company Summary 7.2.2 Vaxart Business Overview 7.2.3 Vaxart Norovirus Vaccine Major Product Offerings 7.2.4 Vaxart Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.2.5 Vaxart Key News & Latest Developments 7.3 Moderna 7.3.1 Moderna Company Summary 7.3.2 Moderna Business Overview 7.3.3 Moderna Norovirus Vaccine Major Product Offerings 7.3.4 Moderna Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.3.5 Moderna Key News & Latest Developments 7.4 UMN Pharma 7.4.1 UMN Pharma Company Summary 7.4.2 UMN Pharma Business Overview 7.4.3 UMN Pharma Norovirus Vaccine Major Product Offerings 7.4.4 UMN Pharma Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.4.5 UMN Pharma Key News & Latest Developments 7.5 Daiichi Sankyo 7.5.1 Daiichi Sankyo Company Summary 7.5.2 Daiichi Sankyo Business Overview 7.5.3 Daiichi Sankyo Norovirus Vaccine Major Product Offerings 7.5.4 Daiichi Sankyo Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.5.5 Daiichi Sankyo Key News & Latest Developments 7.6 Kanghua Biology 7.6.1 Kanghua Biology Company Summary 7.6.2 Kanghua Biology Business Overview 7.6.3 Kanghua Biology Norovirus Vaccine Major Product Offerings 7.6.4 Kanghua Biology Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.6.5 Kanghua Biology Key News & Latest Developments 7.7 Beijing Institute of Biological Products 7.7.1 Beijing Institute of Biological Products Company Summary 7.7.2 Beijing Institute of Biological Products Business Overview 7.7.3 Beijing Institute of Biological Products Norovirus Vaccine Major Product Offerings 7.7.4 Beijing Institute of Biological Products Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.7.5 Beijing Institute of Biological Products Key News & Latest Developments 7.8 Zhifei Bio 7.8.1 Zhifei Bio Company Summary 7.8.2 Zhifei Bio Business Overview 7.8.3 Zhifei Bio Norovirus Vaccine Major Product Offerings 7.8.4 Zhifei Bio Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.8.5 Zhifei Bio Key News & Latest Developments 7.9 China Biotechnology Co., Ltd. 7.9.1 China Biotechnology Co., Ltd. Company Summary 7.9.2 China Biotechnology Co., Ltd. Business Overview 7.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Major Product Offerings 7.9.4 China Biotechnology Co., Ltd. Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.9.5 China Biotechnology Co., Ltd. Key News & Latest Developments 7.10 North China Pharmaceutical 7.10.1 North China Pharmaceutical Company Summary 7.10.2 North China Pharmaceutical Business Overview 7.10.3 North China Pharmaceutical Norovirus Vaccine Major Product Offerings 7.10.4 North China Pharmaceutical Norovirus Vaccine Sales and Revenue in Global (2018-2023) 7.10.5 North China Pharmaceutical Key News & Latest Developments 8 Global Norovirus Vaccine Production Capacity, Analysis 8.1 Global Norovirus Vaccine Production Capacity, 2018-2029 8.2 Norovirus Vaccine Production Capacity of Key Manufacturers in Global Market 8.3 Global Norovirus Vaccine Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Norovirus Vaccine Supply Chain Analysis 10.1 Norovirus Vaccine Industry Value Chain 10.2 Norovirus Vaccine Upstream Market 10.3 Norovirus Vaccine Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Norovirus Vaccine Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
